UNSPSC 51351503: Dimethisterone

This classification denotes a therapeutic progestin with the molecular formula C23H32O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K4MZ02M175, chemically known as 17-alpha-pregn-4-en-20-yn-3-one, 6-alpha,21-dimethyl-17-hydroxy- but generally known as dimethisterone, which bears US NIH Compound Identifier 6607. European Medicines Agency schedules Dimethisterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07173MIG.

UNSPSC 51351503 Dimethisterone, a Commodity code, covers procurement of this synthetic progestin pharmaceutical compound by state and local governments. State and local buyers source dimethisterone primarily through pharmaceutical supply contracts and health-department acquisitions for clinical use, though the code's actual procurement footprint remains limited. Issuing bodies purchasing under this code include state health departments and related public-health agencies; municipal and county health systems; and institutional buyers within state-operated medical facilities and correctional health programs. The specificity of this pharmaceutical ingredient means that procurement is typically embedded within larger pharmaceutical supply agreements rather than solicited as a standalone line item.

The source material contains no recent state or local contract opportunities tagged to UNSPSC 51351503. Without posted RFP, RFQ, IFB, or ITB records in the public domain, the current activity level, geographic distribution, and demand drivers for dimethisterone procurement cannot be characterized. Business development professionals monitoring this code should track state health-department pharmaceutical schedules, correctional-system supply RFPs, and cooperative purchasing vehicle catalogs (such as state group purchasing organizations) for any emergence of dimethisterone line items or ingredient-specific solicitations.